Sending Office: Honorable Brian Higgins
Sent By:
Jessica.Burnell@mail.house.gov

Support Increased Funding for the National Cancer Institute

Current signers (27): Moulton, Wasserman Schultz, Nadler, Cicilline, Rush, Green, Vela, Hastings, Jackson Lee, Pappas, Plaskett, Davis, Van Drew, DeSaulnier, McAdams, Sires, Cárdenas, Sablan, Scott (GA), Raskin, Kim, Moore, Rose, Payne,
Omar, Ocasio-Cortez, Gabbard

Dear Colleague-

Please join us in supporting increased funding for the National Cancer Institute for FY2020.

Cancer is a relentless disease that impacts millions of Americans. Just this year more than 1.7 million people in the US are expected to be diagnosed with cancer, and over 600,000 Americans will die from the disease. Cancer not only impacts individuals and
families across the country, but it also costs our economy more than $216 billion annually in direct treatment costs and lost productivity.

But there is hope. Because of the previous congressional investment in cancer research, more than 15.5 million American cancer survivors are alive today, and we are enjoying a quarter century of sustained declines in cancer mortality. As of 2016, the cancer
death rate for men and women combined has fallen 27 percent from its peak in 1991. This decline translates to about 1.5 percent per year and more than 2.6 million deaths avoided between 1991 and 2016. 

To continue the progress that has led to medical breakthroughs for treatment and therapies for millions of cancer patients, the NCI needs an increased, sustainable federal investment. Therefore,
we are asking that at least $6.522 billion in overall funding be included in the Labor, Health and Human Services, and Education appropriations bill for the National Cancer Institute in Fiscal Year 2020.

If you have questions, or wish to sign onto the letter in support of this critical funding for life-saving research, please contact Jessica Burnell (Jessica.Burnell@mail.house.gov) in Rep. Higgins’s office.
The deadline to sign on is COB, March 25th, 2019.

Sincerely,

Brian Higgins                                                            Peter King

Member of Congress                                                 Member of Congress

Brian Fitzpatrick                                                        

Member of Congress

——————————————————————————————————————————–

March xx, 2019

The Honorable Rosa DeLauro

Chairwoman

Subcommittee on Labor, Health and Human Services, and Related Agencies

Committee on Appropriations

U.S. House of Representatives

Washington, DC 20515

 

The Honorable Tom Cole

Ranking Member

Subcommittee on Labor, Health and Human Services, and Related Agencies

Committee on Appropriations

U.S. House of Representatives

Washington, DC 20515

 

Dear Chairwoman DeLauro and Ranking Member Cole,

As you prepare the Fiscal Year 2020 Labor, Health and Human Services, Education, and Related Agencies appropriations bill, we write to express our support for increased funding for the National Cancer Institute (NCI). 

Cancer is a relentless disease that impacts millions of Americans. Just this year more than 1.7 million people in the US are expected to be diagnosed with cancer, and over 600,000 Americans will die from the disease. Cancer not only impacts individuals and
families across the country, but it also costs our economy more than $216 billion annually in direct treatment costs and lost productivity.

But there is hope. Because of the previous congressional investment in cancer research, more than 15.5 million American cancer survivors are alive today, and we are enjoying a quarter century of sustained declines in cancer mortality. As of 2016, the cancer
death rate for men and women combined has fallen 27 percent from its peak in 1991. This decline translates to about 1.5 percent per year and more than 2.6 million deaths avoided between 1991 and 2016. 

We have made significant progress to reduce the loss of purchasing power experienced by the NCI since Fiscal Year 2003, which marked the end of the five-year doubling of funding for the National Institutes of Health (NIH). With increases in federal investment
in medical research over the last four fiscal years and the passage of the 21st Century Cures Act that included funding for the National Cancer Moonshot Initiative, Congress has demonstrated its bipartisan support for cancer research. However, Moonshot
funding is a small percentage of NCI’s total budget, and in Fiscal Year 2020 the funding going to NCI for this initiative will be cut by just over half from $400 million in 2019 to $195 million in 2020. Even counting the Moonshot, NCI’s budget lags 15.6 percent,
or $1.1 billion, below what it would have been if funding had kept pace with biomedical inflation since 2003.

To continue the progress that has led to medical breakthroughs for treatment and therapies for millions of cancer patients, the NCI needs an increased, sustainable federal investment. Therefore, Congress should provide at least $6.522 billion in overall
funding for the National Cancer Institute in Fiscal Year 2020.

Thank you for your consideration of our request to provide critical funding for this life-saving research.

Sincerely,

Brian Higgins

Member of Congress

 

Peter King

Member of Congress

 

Brian Fitzpatrick

Member of Congress

Related Legislative Issues

Selected legislative information: Appropriations, HealthCare

icon eDC logo e-Dear Colleague version 2.0
 
e-Dear Colleagues are intended for internal House use only.